Chronic hepatitis C

Hepatitis C is an infection caused by the hepatitis C virus (often shortened to HCV). The word hepatitis simply means inflammation of the liver. The liver is a large organ on the right side of your abdomen that cleans your blood, helps you digest food, and stores energy. When the hepatitis C virus settles in the liver, it can slowly cause inflammation and, over many years, scarring.

Doctors describe two phases. Acute hepatitis C is the first six months after infection. During this time, some people clear the virus on their own without any treatment. According to the World Health Organization, roughly 3 in 10 people clear the virus naturally within six months. When the virus stays in the body beyond six months, it is called chronic hepatitis C — a long-term infection.

The most important thing to understand is that chronic hepatitis C is usually a quiet, slow condition, and it is very treatable. The WHO and the U.S. Centers for Disease Control and Prevention (CDC) both report that modern medicines cure more than 95% of people who take them. Around 50 million people worldwide live with chronic hepatitis C, and many do not yet know it, simply because it rarely causes obvious symptoms early on.

The hepatitis C virus comes in several different strains called genotypes. Cleveland Clinic notes there are seven main genotypes, numbered 1 through 7. They differ slightly in their genetic makeup and are more common in some parts of the world than others. Genotype 1, for example, is the most common in the United States.

In the past, knowing the genotype mattered a great deal because different strains needed different drug combinations. Today this is much less of a concern. Many modern medicines are described as pan-genotypic, meaning one treatment works against all the major genotypes. Your specialist may still check the genotype in certain situations, but for most people it no longer changes the basic plan.

Beyond genotype, doctors also describe hepatitis C by how much the liver has been affected. Someone may have chronic infection with a healthy-looking liver, with mild scarring (early fibrosis), or with advanced scarring called cirrhosis. This distinction is described in the diagnosis section below and influences how long treatment lasts and how closely you are monitored.

Chronic hepatitis C is caused by the hepatitis C virus, which spreads through blood-to-blood contact — meaning blood carrying the virus enters another person's bloodstream. It is not spread by hugging, kissing, sharing food or drinks, coughing, or sneezing. The CDC is clear that casual contact does not pass on the virus.

The most common ways the virus spreads include:

• Sharing equipment used to inject drugs, such as needles or syringes — the most common route in many countries.
• Medical or dental care with poor infection control, including reused or improperly sterilised equipment.
• Blood transfusions or blood products received before routine screening began (in the UK, before 1991–1992; donated blood is now screened).
• Tattoos or piercings done with unsterilised equipment.
• Sharing personal items that may carry traces of blood, such as razors or toothbrushes.
• From mother to baby during birth, which is less common.
• Sex involving exposure to blood, which is an uncommon but recognised route.

Certain groups have a higher chance of having been exposed, including people who have ever injected drugs, people who had long-term kidney dialysis, healthcare workers exposed to a needlestick injury, and people living with HIV. Having a risk factor does not mean you have the virus — it simply means testing is worthwhile.

One of the defining features of chronic hepatitis C is that most people feel completely well. The CDC and NHS both emphasise that many people have no symptoms for years, which is exactly why the infection so often goes unnoticed.

When symptoms do appear in the early (acute) phase — usually 2 to 12 weeks after infection — they tend to be vague and flu-like. They can include:

• Tiredness or fatigue
• Fever and aching joints or muscles
• Loss of appetite, nausea, or stomach (abdominal) pain
• Dark-coloured urine and pale stools
• Jaundice — a yellow tint to the skin and the whites of the eyes

In long-standing chronic infection, some people notice persistent tiredness, itchy skin, low mood, or difficulty concentrating, which the NHS describes among possible long-term effects.

When to see a doctor: Speak to a healthcare professional if you have any of the symptoms above, if you think you may have been exposed to the virus, or if you fall into any higher-risk group. Because symptoms are unreliable, the best way to know is a simple blood test — you do not need to wait to feel unwell.

Because chronic hepatitis C is often silent, testing people who may not feel ill is the main way it is found early. This is good news, because finding it before the liver is damaged gives the best chance of a smooth recovery.

The U.S. Preventive Services Task Force (USPSTF) recommends one-time screening for all adults aged 18 to 79, with repeat testing for people who have an ongoing risk (such as continuing to inject drugs). The CDC similarly recommends testing all adults at least once, testing during every pregnancy, and testing anyone with a possible exposure.

Screening is done with a straightforward blood test, and the result usually comes back within a couple of weeks. There is no special preparation required. If you are unsure whether you have ever been tested, it is reasonable to ask your doctor — a single test can provide real peace of mind.

Diagnosing hepatitis C is usually a clear, step-by-step process based on blood tests.

Step 1 — the antibody test (anti-HCV). This checks whether your immune system has ever reacted to the virus. A positive result means you have been exposed at some point, but it does not by itself confirm a current infection, because some people clear the virus naturally.

Step 2 — the RNA (PCR) test. If the antibody test is positive, a second test looks for the virus's genetic material in your blood. A positive RNA test confirms an active, current infection. The WHO notes that around 3 in 10 people who test antibody-positive have actually cleared the virus and will be RNA-negative.

If active infection is confirmed, your specialist will assess how the liver is doing. This may include:

• Blood tests measuring liver function and, sometimes, the genotype of the virus.
• FibroScan (transient elastography) — a quick, painless scan, similar to an ultrasound, that estimates the stiffness (scarring) of the liver.
• Ultrasound or other imaging to look at the liver directly.
• A liver biopsy (taking a tiny tissue sample) in selected cases, though this is needed far less often now that scans are available.

This staging matters because it tells the team whether scarring is mild or has progressed to cirrhosis, which guides treatment length and follow-up.

Treatment for chronic hepatitis C has changed dramatically and for the better. Today it centres on a group of tablets called direct-acting antivirals (DAAs). These medicines block the steps the virus needs to copy itself, allowing the body to clear it.

Key points about modern treatment, drawn from the CDC, WHO, and NHS:

• Treatment is usually tablets taken once a day for 8 to 12 weeks (sometimes up to 24 weeks if there is advanced cirrhosis).
• It is taken at home; it does not involve the older injections that once caused difficult side effects.
• Common combinations include sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, ledipasvir/sofosbuvir, and elbasvir/grazoprevir.
• Side effects, when they occur, are usually mild — for example tiredness, headache, or nausea.

The goal of treatment is a sustained virologic response (SVR), which means the virus can no longer be found in your blood 12 weeks after finishing the tablets. An SVR is what doctors mean by a cure. The CDC reports that more than 95% of people treated achieve this.

Treatment is guided by a multidisciplinary team — typically a hepatologist or gastroenterologist (liver and digestive specialists), specialist nurses, and a pharmacist, with input from others as needed. Where cirrhosis or liver cancer is present, additional specialists such as surgeons or transplant teams may be involved. Supportive care — managing other health conditions, reviewing alcohol use, and updating vaccinations — is part of looking after the liver as a whole.

The overall outlook for chronic hepatitis C today is genuinely encouraging, especially when it is found and treated. With modern tablets, the CDC and WHO report that more than 95% of people are cured. Once the virus is cleared, the liver often has a real chance to recover, and earlier-stage scarring may improve over time.

It helps to understand why treatment matters. Left untreated over many years, chronic hepatitis C can lead to cirrhosis (heavy scarring of the liver) and, less commonly, liver cancer or liver failure. Cleveland Clinic describes population-level estimates that, without treatment, about 1 in 5 people develop cirrhosis within around 20 years, and a smaller number go on to develop liver cancer over roughly 30 years. The progression is usually faster in people who also drink heavily or who have hepatitis B or HIV.

These figures describe groups of people studied over time. They are not a prediction for any individual, and they reflect the natural course without modern treatment. Your own outlook depends on many things — when the infection is found, the health of your liver, whether you are treated, and your other circumstances — which is something only your own specialist can discuss with you.

Living with chronic hepatitis C, and life after a cure, is very manageable for most people. While you have the infection, simple steps protect your liver and others around you:

• Look after your liver: limit or avoid alcohol, eat a balanced diet, and ask your doctor before taking new medicines or supplements, since some are processed by the liver.
• Prevent passing it on: do not share razors, toothbrushes, or any equipment that could carry blood, and cover any cuts.
• Ask about vaccinations against hepatitis A and B, which protect a liver already under strain.

After treatment, follow-up usually includes a blood test about 12 weeks after the last tablet to confirm the virus is gone (the SVR described earlier). If you had significant scarring or cirrhosis before treatment, your team will likely recommend continued monitoring — such as periodic ultrasound scans — even after a cure, because the liver still needs watching. Being cured does not make you immune; it is possible to be re-infected through a new blood exposure, so the same everyday precautions still apply.

Many people also find emotional support helpful, whether from family, a patient organisation, or a counsellor. A hepatitis C diagnosis can feel worrying at first, but it is, for most people, a treatable and curable condition.

If you are considering arranging hepatitis C care abroad, it helps to understand what shapes the overall cost and how to prepare. We do not list prices here, because every plan is genuinely individual — the right approach is a personalised estimate after a specialist reviews your case.

Factors that typically affect cost and planning include:

• Which tests you need — for example confirmatory RNA testing, genotype testing, and a liver-stiffness scan such as FibroScan.
• The stage of liver health — whether there is mild scarring or cirrhosis, which can change the length of treatment and the level of monitoring.
• The medicines and treatment duration chosen by your specialist (commonly 8–24 weeks of tablets).
• Specialist consultations and follow-up tests, including the post-treatment blood test to confirm a cure.
• Any other conditions (such as hepatitis B or HIV) that need coordinated care.
• Travel and accommodation, if you are coming from another country.

To prepare, gather your medical records: any previous hepatitis C antibody and RNA results, genotype if known, recent liver blood tests and scans, a current list of all medicines and supplements, and your vaccination history. Having these ready allows a specialist team to give you accurate advice quickly. The best next step is a free consultation, where your records can be reviewed and a personalised estimate prepared.

Turkiye (Turkey) has become a well-known destination for medical travel, with many hospitals offering specialist gastroenterology and liver (hepatology) services and experience caring for international patients. As a concierge service, BergemHealth helps arrange this care, but the most important decisions are clinical ones made with a qualified specialist.

Rather than looking for superlatives, focus on what you can verify when choosing where to be treated:

• Accreditation: ask whether the hospital holds recognised quality accreditation (for example, Joint Commission International, known as JCI) and is licensed by the Turkish Ministry of Health.
• Specialist team: confirm that a hepatologist or gastroenterologist experienced in viral hepatitis leads your care, supported by the wider multidisciplinary team.
• Proper diagnostics: a good centre will confirm active infection with an RNA test and assess your liver before recommending treatment, rather than prescribing medicines straight away.
• Clear follow-up: check how the post-treatment SVR test and any ongoing monitoring will be handled, including after you return home.
• Transparent information: you should receive clear explanations, a written plan, and a personalised cost estimate before you commit.

Always feel free to seek a second opinion and to ask as many questions as you need. A trustworthy team will welcome them.

There is currently no vaccine for hepatitis C, as the WHO and MedlinePlus confirm — though there are vaccines for hepatitis A and B, which protect the liver in other ways. Prevention therefore focuses on avoiding blood-to-blood contact:

• Never share needles, syringes, or any drug-injecting equipment. If you use drugs, harm-reduction services can provide sterile equipment and support.
• Choose licensed, hygienic providers for tattoos, piercings, and similar procedures, and make sure equipment is sterile and single-use where appropriate.
• Do not share personal items that may carry traces of blood, such as razors or toothbrushes.
• Practise safer sex, particularly where there may be blood exposure; condoms reduce risk.
• Ensure medical and dental care uses properly sterilised equipment — a particular consideration when travelling.

If you have ever been at risk, the single most useful self-care step is simply to get tested. Hepatitis C is one of the few chronic viral infections that can now be cured for most people, and early detection makes everything that follows easier. If you have already been treated and cured, keep up the same precautions, since a new exposure can cause re-infection.